Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorEliaçık, Sinan
dc.contributor.authorÇil, Gülsüm
dc.date.accessioned2023-05-24T11:16:30Z
dc.date.available2023-05-24T11:16:30Z
dc.date.issued2023en_US
dc.identifier.citationEliaçık, S., & Çil, G. (2023). Case of cerebrotendinous xanthomatosis with giant xanthomas and literature review. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 59(1), 52.en_US
dc.identifier.issn1687-8329
dc.identifier.urihttps://hdl.handle.net/11491/8468
dc.description.abstractIntroduction Cerebrotendinous xanthomatosis (CTX) is a rare autosomalrecessive disease that occurs as result of mutation in the CYP27A1 gene. Theclinical presentation of the disease is quite wide. We planned to briefyreview the literature with this case diagnosed as a CTX. Case A 50-year-old male patient was admitted to the neurologyoutpatient clinic complaining of progressive worsening of his walking, andswelling in his legs. Mild mental retardation was detected in our patient. Inaddition to the visual impairment that would be explained by cataracts, he hadxanthomas in both lower extremities. Signs related to bilateral cataractsurgery and intraocular lens were detected during an eye examination. Therewere no abnormal fndings in electroencephalography, electroneuromyography, andbrain magnetic resonance imaging of the patient, whom we learned that hervisual impairment started in childhood. The Mignarri Suscipion Index index wascalculated as 275. A genetic examination was requested and the CYP27A1 gene wasp.A216P (c.The mutation 646G>C) (CM044609) was detected as homozygous. Conclusion Due to the lowawareness of CTX and the variability of its clinical fndings, its diagnosis maybe delayed for years, as in our patient. When diagnosed, most patients may havesevere, often irreversible neurological damage. With the early recognition ofthe CTX and the start of treatment, patients can have a chance to quality life. Keywords Cerebrotendinous xanthomatosis, Xanthomatosis, Cholestanol, Osteoporosis, Juvenile bilateral cataract, CYP27A1 geneen_US
dc.language.isoengen_US
dc.publisherSPRINGERen_US
dc.relation.ispartofEGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERYen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectCerebrotendinous xanthomatosisen_US
dc.subjectXanthomatosisen_US
dc.subjectCholestanolen_US
dc.subjectOsteoporosisen_US
dc.subjectJuvenile bilateral cataracten_US
dc.subjectCYP27A1 geneen_US
dc.titleCase of cerebrotendinous xanthomatosis with giant xanthomas and literature reviewen_US
dc.typeotheren_US
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.authorid0000-0002-9415-0039en_US
dc.authorid0000-0001-7650-0210en_US
dc.identifier.volume59en_US
dc.identifier.issue1en_US
dc.relation.publicationcategoryDiğeren_US
dc.identifier.doi10.1186/s41983-023-00644-4en_US
dc.description.wospublicationidWOS:000970074100002en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess